Cannabis Law Report
JANUARY 15, 2019
British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.
Project CBD
MARCH 21, 2023
That’s what appeared to happen in rats injected with the synthetic CB1 agonists WIN55,212‐2 and CP55,940 in a 2010 study 4 and THC and CBD in a 1:1 ratio in a 2011 follow-up study. 268,1-2 (2010): 145-50. Laryngoscope investigative otolaryngology vol. 5,6 1147-1155. 2020, doi:10.1002/lio2.479 Zheng, Yiwen et al. Hearing research vol.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 3, 2021
Many western countries have allowed using these Cannabis oils as a medicine to cure serve epilepsy and related diseases. However, it contains an equivalent blend of THC and Cannabis oil yet would not be appropriate for treating youngsters with epilepsy like Billy. An exploration did at the University of Nottingham in 2010.
Veriheal
MARCH 19, 2025
Medical marijuana ended up on the ballot once again in 2010, but this initiative also failed at 36% in favor to 63% not in favor. However, the ballot did fail, with a close call of 47% in favor and 52% not in favor. It would be another ten years before this issue was back on the ballot.
Veriheal
MAY 17, 2023
As of 2021, just two Singaporeans with treatment-resistant epilepsy have been approved to use medicinal cannabis in the form of Epidiolex. He had an IQ of 69 and had been stuck on death row since 2010. However, cannabis is usually only considered as a last resort after all other treatment options have been exhausted.
Greencamp
AUGUST 16, 2018
The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.
Cannabis Law Report
MAY 9, 2022
The company is following in the footsteps of GW Pharmaceuticals, a trailblazer that developed the first cannabis-based medicine to be licensed in the UK in 2010, Sativex for multiple sclerosis, which costs about £2,000 a year. However, NHS prescribing of the mouth spray remains very limited and varies across the country.
Expert insights. Personalized for you.
71 
Let's personalize your content